|
|
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
Jean-Luc Harousseau
,
Herve Avet-Loiseau
,
Michel Attal
,
Catherine Charbonnel
,
Frederic Garban
,
et al.
Journal articles
hal-00821143v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Claire Fabre
,
Serge Koscielny
,
Mohamad Mohty
,
Nathalie Fegueux
,
Didier Blaise
,
et al.
Journal articles
hal-00849621v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Double umbilical cord blood transplantation for hematological malignancies: a long- term analysis from the SFGM-TC registry.
Hélène Labussière Wallet
,
Mohamad Sobh
,
Stéphane Morisset
,
Marie Robin
,
Nathalie Fegueux
,
et al.
Journal articles
hal-00849674v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.
Philippe Moreau
,
Frédéric Garban
,
Michel Attal
,
Mauricette Michallet
,
Gérald Marit
,
et al.
Journal articles
hal-00821148v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.
Gandhi Damaj
,
Alain Duhamel
,
Marie Robin
,
Yves Beguin
,
Mauricette Michallet
,
et al.
Journal articles
inserm-00821506v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Mauricette Michallet
,
Quoc-Hung Le
,
Mohamad Mohty
,
Thomas Prébet
,
Franck Nicolini
,
et al.
Journal articles
inserm-00484237v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Marie Robin
,
Reza Tabrizi
,
Mohamad Mohty
,
Sabine Furst
,
Mauricette Michallet
,
et al.
Journal articles
hal-00849650v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial
Didier Blaise
,
Raynier Devillier
,
Anne-Gaelle Lecoroller-Sorriano
,
Jean-Marie Boher
,
Agnès Boyer-Chammard
,
et al.
Journal articles
hal-02167058v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Reduced-intensity conditioning before allogeneic hematopoietic stem cell transplantation in patients over 60 years: a report from the SFGM-TC.
Patrice Chevallier
,
Richard M Szydlo
,
Didier Blaise
,
Reza Tabrizi
,
Mauricette Michallet
,
et al.
Journal articles
hal-00849660v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
Patrice Chevallier
,
Mohamad Mohty
,
Bruno Lioure
,
Gérard Michel
,
Nathalie Contentin
,
et al.
Journal articles
inserm-00484234v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02
Xavier Leleu
,
Michel Attal
,
Bertrand Arnulf
,
Philippe Moreau
,
Catherine Traulle
,
et al.
Journal articles
hal-01064417v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
Michel Attal
,
Valerie Lauwers-Cances
,
Gerald Marit
,
Denis Caillot
,
Philippe Moreau
,
et al.
Journal articles
hal-00852275v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|